Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

Share Price is delayed by 15 minutes
Get Live Data
109.50    2.00 (1.86%)
Bid:
105.50
Ask:
106.50
Spread: 1.00 (0.948%)
Market Cap: £107.91m
ECEL Live PriceLast checked at - London Stock Exchange

Intraday Eurocell Share Chart

Directorate changes

9 Feb 2026 13:00

RNS Number : 2839S
Eurocell plc
09 February 2026
Β 

9 February 2026

EUROCELL PLC

("Eurocell" the "Group" or the "Company")

Directorate Changes

Β 

Eurocell plc, the leading UK manufacturer and distributor of door and window products to the trade, today announces that Darren Waters will step down as Chief Executive Officer (CEO) with immediate effect. The Board believes that to achieve our strategic objectives in this critical year it is in the best interests of the Company to have surety of leadership and a seamless handover, therefore the Board has appointed Will Truman as CEO commencing immediately.

​Will Truman vacates his role as CFO Designate. Michael Scott has agreed to postpone his retirement and continue as CFO, whilst the Board commences a full and rigorous recruitment process to identify a permanent CFO for the business.

​Derek Mapp, Chair, commented: "On behalf of myself and the Board, I would like to thank Darren for his leadership over the last 3 years, which included the acquisition of Alunet and the expansion and growth of window and door sales through the branches. He has contributed significantly to the culture change we are undertaking in the business. We wish him well in his future endeavours."

Β 

Enquiries:

Β 

Eurocell plc

Will Truman, Chief Executive Officer +44 (0) 1773 842 105

Michael Scott, Chief Financial Officer +44 (0) 1773 842 140

Β 

Teneo

Nick de Bunsen +44 (0) 7825 575 258

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAUKSURNNUURAR
Date   Source Headline
15th Feb 20246:00 pmRNSHolding(s) in Company
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSDirector/PDMR Shareholding
13th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSNon-executive Directors' Share Purchase Plan
1st Feb 20247:00 amRNSTransaction in Own Shares
30th Jan 20247:04 amRNSTransaction in Own Shares
29th Jan 20247:00 amRNSTransaction in Own Shares
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSDirectorate Change
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSYear End Trading Update
23rd Jan 20247:00 amRNSLaunch of Share Buyback Programme
27th Dec 20237:00 amRNSHolding(s) in Company
19th Dec 20234:30 pmRNSHolding(s) in Company
29th Nov 20234:30 pmRNSDirector/PDMR Shareholding
14th Nov 20234:30 pmRNSDirector/PDMR Shareholding
3rd Nov 20234:30 pmRNSHolding(s) in Company
2nd Nov 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20234:30 pmRNSHolding(s) in Company
16th Oct 20234:30 pmRNSDirector/PDMR Shareholding
13th Oct 20234:30 pmRNSHolding(s) in Company
22nd Sep 20237:00 amRNSInvestor Presentation
21st Sep 20234:30 pmRNSDirector/PDMR Shareholding
7th Sep 20236:30 pmRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSHalf-year Results
4th Sep 20237:00 amRNSBlock listing Interim Review
9th Aug 20234:30 pmRNSDirector/PDMR Shareholding
25th Jul 20237:00 amRNSTrading Update - In Line with Expectations
17th Jul 20237:00 amRNSHolding(s) in Company
18th May 20237:00 amRNSHolding(s) in Company
16th May 20234:00 pmRNSHolding(s) in Company
16th May 20237:00 amRNSHolding(s) in Company
15th May 20235:00 pmRNSChanges to Board Committee Memberships
12th May 20237:00 amRNSTrading Update and Board Changes
11th May 20234:30 pmRNSResult of AGM
10th May 20237:00 amRNSDirector/PDMR Shareholding
24th Apr 20237:00 amRNSDirector/PDMR Shareholding
17th Apr 20237:00 amRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSDirector/PDMR Shareholding
11th Apr 20237:00 amRNSAnnual Financial Report
20th Mar 20237:00 amRNSInvestor Presentation
17th Mar 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.